Search

Your search keyword '"Decock, Julie"' showing total 158 results

Search Constraints

Start Over You searched for: Author "Decock, Julie" Remove constraint Author: "Decock, Julie" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
158 results on '"Decock, Julie"'

Search Results

1. An integrated tumor, immune and microbiome atlas of colon cancer.

4. Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry

5. Uncovering a neurological protein signature for severe COVID-19

7. The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer

9. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

12. Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study

14. The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival.

15. High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder

16. Auto-immunoproteomics analysis of COVID-19 ICU patients revealed increased levels of autoantibodies related to the male reproductive system

18. Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

20. Profiling the autoantibody repertoire reveals autoantibodies associated with mild cognitive impairment and dementia.

21. Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study

25. Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential

26. Auto-Immunoproteomics Analysis of COVID-19 ICU Patients Revealed Increased Levels of Autoantibodies Related to Male Reproductive System

27. Additional file 9 of Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

28. Additional file 6 of Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

29. Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry

30. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

31. Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy

32. Additional file 8 of Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

33. Additional file 1 of Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

34. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15

37. Robust prognostic signatures derived from proteomic panel profiling of plasma from patients with severe COVID-19 complications

42. Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response

43. Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy.

45. Conditional activation of immune-related signatures and prognostic significance: a pan-cancer analysis

47. A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification

49. Additional file 1: Table S1. of Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function

50. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Catalog

Books, media, physical & digital resources